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Summary No numerical aberration ofchromosomes that might be specific for prostate cancer has so far been
established. We used fluorescence in situ hybridisation (FISH) with centromere-specific probes for
chromosomes 7, 8, 17, X and Y to establish the distribution of centromere copy numbers in frozen-stored
or freshly prepared samples of benign prostate hypertrophy (BPH) and to detect numerical aberrations of these
chromosomes in 28 prostate cancers from Japanese men. There was no significant difference in the data of
centromere copy numbers between fresh and frozen-stored tissue. The most common aberration in prostate
cancers was a gain ofchromosome 8 (57%), with numerical aberration ofchromosome 7 being the second most
frequent anomaly (50%). Numerical aberration of chromosome 7 is most significantly associated with a higher
Gleason score (GS) (P<0.005) or with lymph node metastasis (P<0.001). Numerical aberration of several
chromosomes, including chromosomes 7 and/or 8, was common in aggressive prostate cancers. Loss of
chromosome Y was detected in only 4% of cases. FISH analysis thus proved to be a useful method for
detecting numerical aberrations of individual chromosomes, with application to touch preparations of frozen-
stored tissue having the advantage of exact sampling of cancer foci. The results suggest that numerical
aberration of chromosome 7 is associated with aggressive tumour behaviour and poor prognosis of patients
with prostate cancer. The association between genetic change and chromosomal abnormality should be studied
in detail.
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Fluorescence in situ hybridisation (FISH) has been used to
hybridise specific nucleic acid sequences with complemental
DNA fragments, revealing their location on chromosomes
and their copy numbers (Trask et al., 1990). Compared with
conventional metaphase cytogenetics or karyotyping analy-
sis, FISH allows more rapid enumeration of specific
chromosomes and detection of chromosomal alterations
even in interphase nuclei (interphase cytogenetics) as well
as in metaphase nuclei (Cremer et al., 1986; Pinkel et al.,
1986). This technique does not always require tissue
culturing and can be applied to solid tumours (Persons et
al., 1993; Devilee et al., 1988) and even formalin-fixed,
paraffin-embedded tissues (Micale et al., 1993; Persons et al.,
1994). FISH has been demonstrated to be more sensitive
than flow cytometry (FCM) for detecting aneuploidy
(Takahashi et al., 1994; Visakorpi et at., 1994), and the
methodology can detect numerical aberrations of individual
chromosomes at levels impossible with FCM and image
cytometry (ICM). FCM also has limitations regarding minor
quantitative DNA changes (Hopman et al., 1990). While the
application of FISH to studies of the association between
DNA aneuploidy and prognosis has attracted attention, no
numerical aberration of any chromosome which might be
specific for prostate cancer has so far been established.
Furthermore, it is unclear whether the numerical aberrations
of individual chromosomes that have been detected
(Takahashi et al., 1994; Visakorpi et al., 1994; Zitzelsberger
et al., 1994) have pathological and/or clinical significance.
However, these previous studies of prostate cancer analysed
only a few cases or used limited numbers of cx-satellite DNA
probes.
To our knowledge, there has been no detailed study of
chromosomal aberrations in Japanese cases of prostate
cancer. The frequency of ras mutations varies according to
ethnic groups (Watanabe et al., 1994) and the difference in
the p53 mutational spectrum between Japanese and American
prostate cancer patients (Watanabe et al., 1994) has been
reported. These may point to variation in the underlying
aetiological factors and encouraged us to study numerical
aberrations of chromosomes in prostate lesions developing in
Japanese men.
Distributions of centromere copy number were first
examined by FISH using frozen-stored and freshly prepared
samples of benign prostate hypertropy (BPH) in order to
determine the applicability of the former type of sample. The
main aim ofthis study was to identify numerical aberrations of
chromosomes 7, 8, 17, X and Y in prostate cancers in Japanese
men and to assess their pathological and clinical significance.
Materials and methods
Sample preparation
Fresh BPH samples were obtained from five retropubic
prostatectomies and three total cystoprostatectomies. The
resected prostatic tissues were cut with a disposable blade and
lightly touched on precleaned slides. After air drying, the slides
were incubated in 75 mM KCI for 20 min at 37°C and fixed in
freshly prepared Canoy's solution (three volumes ofmethanol
and one volume of acetic acid). They were air dried at room
temperature and stored at -20°C until subsequent analysis.
The touched tissues were subdivided. Portions were taken for
histological examination to confirm the absence ofcancerous or
premalignant lesions. Among the eight BPH samples, six were
frozen and stored after the initial touch preparation. Frozen-
stored tissues were then slowly thawed in cold phosphate-
buffered saline (PBS) (4°C), and further touch preparations
were then made using the same method.
Samples from a total of 28 cases of prostatic cancer were
collected, including 22 by radical prostatectomy, one by
retropubic prostatectomy, three at autopsy and two from
metastatic lesions (lymph node and vertebra). Twenty of the
twenty-eight patients had received endocrine therapy before
the excision of the tumour. The resected prostatic tissues were
randomly cut at several places with disposable blades and
lightly touched on precleaned slides. Samples were then
stored after freezing with portions being formalin-fixed for
histopathological diagnosis of paraffin-embedded sections.
Only samples in which over 80% of the area was occupied by
cancer and in which prostatic intraepithelial neoplasia (PIN)
and adenomatous hyperplasia could be seen were used.
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Frozen section was also prepared with a cryostat to confirm
the presence of cancer. Cancerous tissues were thawed and
touch preparations made as mentioned above. Histological
classification was made according to the Gleason score
method and the TNM system.
Probes
ac-satellite DNA probes specific for centromeric regions of
chromosomes 7 (D7Z1), 8 (D8Z1), 17 (D17Z1), X (DXZl)
and Y (DYZI) were used. These probes had been labelled
with digoxigenin (Oncor, Gaithersburg, MO, USA).
Fluorescence In situ hybridization (FISH)
FISH was carried out according to the manufacturer's
instructions (chromosome in situ hybridisation system, dual
colour detection for whole cells or metaphase chromosomes,
fluorescence microscopy; Oncor) with slight modifications.
Frozen slides were thawed at room temperature, dehydrated
in ethanol and air dried. Each slide was treated with
RNAase (100 yg ml-' in 2 x standard saline citrate (SSC);
Boehringer Mannheim, Germany), covered with a coverslip
and placed in a moist chamber at 37°C for 20 min. Slides
were rinsed in 2 x SSC, dehydrated in ethanol, prewarmed
at 60°C for 30 min, denatured in 70% formamide/2 x SSC at
70°C for 2 min and dehydrated in cold ethanol. A probe
mixture consisting of 1.5 yl of a-satellite DNA probe and
30 ,l of Hybrisol VI (65% formamide/2 x SSC, Oncor) per
specimen was denatured at 70°C for 5 min in a water bath.
The probe mixture, quickly chilled on ice for 2 min, was
applied to slides which had been prewarmed to 37°C, and
hybridisation was allowed to proceed overnight at 370C in a
moist chamber. The slides were post-hybridised and were
washed three times at 43°C for 5 min in 65% formamide/
2 x SSC and two times at 37°C for 4 min in 2 x SSC (pH
7.0). For detection of probes, the slides were rinsed in 3%
bovine serum albumin (BSA)/0.001% Tween 20/4 x SSC and
incubated with anti-digoxigenin-fluorescein Fab fragments
(Boehringer Mannheim) in 1% BSA/0.001% Tween 20/
4 x SSC at 370C for 30 min. After three washings in 0.001%
Tween 20/4 x SSC at 37°C for 5 min, interphase nuclei were
counterstained with propidium iodide (PI) in 90% glycol
with DABCO (1,4-diazabicyclo [2.2.2.] octane; Sigma, St
Louis, USA). The slides were covered with coverslips, stored
at 4°C for 20 min and examined with an epifluorescence
photomicroscope using an FITC and PI exciter filter cube
(WIB; Olympus, Japan). The hybridising signals in 350-450
interphase nuclei were counted. In order to allow a proper
evaluation of signals, the previously published criteria at
Polak et al. (1990) were adapted. Counted nuclei were
isolated and were placed so that they were not overlapping,
not obstructed by thick cytoplasm and had signals with
more or less the same homogeneous fluorescence intensity.
Minor hybridisation spots were not counted. Spots in a
paired arrangement (split spots) were counted as one signal.
The percentages of nuclei which had one, two, three, four or
more than five (> 5) signals per one nuclei were calculated
for each specimen.
In order to obtain control values, centromere copy numbers
for the five chromosomes were evaluated using eight benign
prostatic tissues and the criteria described previously
(Takahashi et al., 1994; Brown et al., 1994) with slight
modifications. The mean+s.d. for centromere copy numbers
ofthe five chromosomes are summarised in Tables I and II. The
average percentages of nuclei with two signals (disomy) for
chromosomes 7, 8 and 17 were more than 91% (Figure 1a and
b). The total percentages ofnuclei with more than three signals
(tetrasomy and other aneusomies) were quite low (<1.5%).
The average percentages of nuclei with single signals of these
three chromosomes were less than 6%. The average percentage
ofnuclei with single signals ofchromosomes X and Y exceeded
93%. There was no significant difference in the distributions of
centromere copy numbers between fresh and frozen-stored
Table I Centromere copy numbers in fresh BPH samples
Copy numbere
Chromosome 1 2 3 4 5
7 3.7+1.3 93.8+2.1 1.5+0.9 0.4+0.4 0+0.1
8 4.7+1.6 92.4+1.6 1.0+0.7 0.4+0.2 0+0.3
17 5.7+1.8 91.5+1.5 1.1+0.7 0.5+0.4 0+0
X 96.4+1.3 3.1+1.0 0.2+0.3 0.1+0.2 0+0
Y 93.6+2.0 5.2+1.6 0.1+0.1 0.1 +0.1 0+0
aMean and standard deviation values for percentages of different
centromere copy numbers for eight cases of BPH.
Table II Centromere copy numbers in frozen BPH samples
Copy numbera
Chromosome 1 2 3 4 5
7 3.7+1.7 93.6+1.3 2.0+1.1 0.7+0.6 0+0
8 3.7+1.9 93.9+1.5 1.8+0.9 0.6+0.4 0+0
17 5.1+1.7 92.1+2.0 1.9+1.0 0.9+0.7 0+0.1
X 96.3+1.1 3.2+1.0 0.9+1.2 0.1+0.1 0+0
Y 94.4+1.7 5.3+1.5 0.3+0.4 0+0 0+0
aMean and standard deviation values for percentages of different
centromere copy numbers for six cases of BPH.
specimens. Cut-off values were determined based on the
mean +3 s.d. If the percentage ofnuclei containing one signal
was more than 12% forchromosome 7, 8 or 17, the tumour was
considered as having a monosomic population. The cut-off
values for three (trisomy), four (tetrasomy) and more than five
(hypertetrasomy) signals forchromosome 7, 8 and 17 were 7%,
6% and 5% respectively. Ifthepercentage ofnuclei ofa tumour
exceeded the cut-offvalue at three or more points, we assumed
that it had two or more cell populations with regard to
numerical aberrations of chromosomes. For chromosomes X
and Y, the cut-off values for two signals and >3 signals were
10% and 5% respectively. A tumour was considered to have a
cell population without signals for chromosome Y (loss of
chromosome Y) if the percentage ofnuclei without any signal
was more than 10% in two different trials. Ifthe percentages of
nuclei containing three and four signals simultaneously
exceeded cut-offvalues, the more frequent one was selected as
the numerical aberration. Aneuploid tumours were defined as
those that had aneusomic population ofat least one ofthe five
chromosomes (modal copy number of0, 1, 3, 5 and so forth for
the centromeres of chromosome 7, 8 and 17; modal copy
numberof0, 3 and so forth forthe centromeres ofchromosome
X and Y). Tetraploidy tumours defined as those that had
tetrasomic population of all five chromosomes (modal copy
number of 4 for the centromeres of chromosome 7, 8 and 17;
modal copy number of2 for the centromeres ofchromosome X
and Y).
Statistical analyses
Centromere copy numbers of interphase nuclei of fresh and
frozen-stored prostatic tissue were compared using the
Mann-Whitney test. Correlations between FISH analysis
and pathological data were analysed with the Fisher's exact
test. Statistical analyses were performed using a software
program (Stat View J; Abacus Concepts, Berkeley, CA, USA)
on a Macintosh Quadra 840AV computer.
Results
Numerical aberrations of chromosomes in prostate cancer
Fish with a-satellite DNA probes was carried out on 28
prostatic cancers, and numerical aberrations of one or more
chromosomes per tumour were detected in 20 (71%) cases
(Table III). The most frequent aberration was a gain of
chromosome 8, which was detected in 16 (57%) of the 28Chromosome aberrations in prostate cancer
H Matsuura et al
Figure 1 FISH with centromere-specific probes performed on touch preparation slides. (a) Fresh BPH specimen with nuclei
showing two signals for chromosome 7. (b) Frozen BPH specimen with nuclei showing two signals for chromosome 7. (c) Frozen
cancerous specimen (case 1) with nuclei showing three signals for chromosome 8. (d) Fresh cancerous specimen (case 28) with nuclei
showing four signals and >5 signals for chromosome 7.
Table III Numerical aberrations of chromosomes and pathology of 28 prostate cancers
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Tetraploid
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Aneuploid
ap, prostate; V, metastasis to vertebra; LN, metastasis to lymph node. bN, no numerical aberration; >5, hypertetrasomy.
cancers (Figure Ic). Trisomy was the most common (8/16) with
tetrasomy and hypertetrasomy being detected in 7/16 and 4/16
of the tumours respectively.
Numerical aberration of chromosome 7 was detected in 14
(50%) of the 28 tumours, trisomy and tetrasomy being found
in 4 and 10 of the 28 tumours respectively. In six of these
tumours, hypertetrasomy of chromosome 7 was detected
together with trisomy or tetrasomy (Figure Id).
Numerical aberrations of chromosomes 17, X and Y were
detected in 11 (39%), 9 (32%) and 6 (21%) of the 28 tumours.
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Table IV Relation between numerical aberrations of chromosomes
and the total Gleason score (GS)
Numerical
aberration
Chromosome (number of cases)
7
8
17
x
y
Diploid (
Aneuploid (
*P<0.005. **P<0.05.
(14)
(14)
(16)
(12)
(10)
(18)
(8)
(20)
(6)
(22)
'11)
'16)
Total GS
3-7
5
13
8
10
4
14
2
16
1
17
8-9 Mean+s.d.
9
1
8
2
6
4
6
4
5
5
7.4+ 1.1*
5.8+1.9
7.1+ 1.4
5.9+2.0
7.0+ 1.7
6.4+ 1.8
7.4+ 1.5**
6.3 + 1.8
7.7+ 1.4**
6.3+1.8
8 3 6.0+2.1
10 6 6.9+1.4
Table V Relation between numerical aberrations and TNM stages
Numerical
aberration T stage N stage
Chromosome (number of cases) pT2 pT3 pT4 pNO pNJ,2
+ (12) 3 7 2 2 10*
7 - (13) 3 10 0 12 1
+ (13) 3 8 2 4 9**
8 - (12) 3 9 0 10 2
+ (8) 1 6 1 2 6
17 - (17) 5 1 1 1 12 5
+ (6) 1 5 0 1 5
X - (19) 5 12 2 13 6
+ (4) 0 4 0 0 4**
Y (21) 6 13 2 14 7
Diploid (11) 3 7 1 8 3
Aneuploid (13) 3 9 1 6 7
*P<0.001. **P<0.05.
Loss (no signal) of chromosome Y was detected in two
tumours (7%). Loss of chromosomes 7, 8, 17 and X was not
detected.
Twelve (75%) of the 16 cases with numerical aberrations
of chromosome 8 also had changes in signals for
chromosome 7. Numerical aberration of two or more
chromosomes was detected in 13 cases (46%).
Using the criteria defined and described in Materials and
methods, diploid, one tetraploid and 16 aneuploid
tumours were identified by FISH.
Correlation of FISH results with clinicopathological data
Tables IV and V summarise data for relationships between
numerical aberrations of chromosomes and clinicopathologi-
cal features. Associations between a high Gleason score (GS)
and numerical aberrations were significant for chromosomes
7 (P<0.005), X and Y (P<0.05). The 25 samples obtained at
radical prostatectomy or autopsy were analysed according to
the TNM system. Pathological staging was not available for
the remaining three cases because histological examinations
of the prostate gland and regional lymph nodes were
incomplete. Numerical aberrations of individual chromo-
somes did not statistically correlate with T stage. Sixteen of
the 19 advanced T-stage (pT3 or pT4) tumours had numerical
aberrations of chromosomes 7, 8, 17, X or Y. All but one of
the tumours that showed tetrasomy or hypertetrasomy were
in advanced T stages. The association between lymph node
metastasis and numerical aberration was most significant for
chromosomes 7 (P<0.005), 8 and Y (P<0.05). The primary
tumours (pNO) without lymph node metastases had a lower
frequency of numerical aberrations of chromosome 7 (14%).
In contrast, 88% of the pNI tumours and all of the pN2
tumours were positive, and nine (82%) primary tumours
(pN1,2) with lymph node metastasis had numerical aberra-
tions of two or more chromosomes which included
chromosome 7.
Among the cases with GS<7, numerical aberrations of
chromosome 7 were detected in all those demonstrating
lymph node metastasis. All cases with tetrasomy or
hypertetrasomy were primary tumours (stage Dl,2) with
metastasis to lymph node or other sites. Of these, 12 (86%)
had numerical aberrations of two or more chromosomes.
No significant relationships were found between ploidy
pattern (as determined by FISH) and GS.
Using the criteria defined and described in Materials and
methods, we identified 11 diploid (39%), one tetraploid (4%)
and 16 aneuploid (57%) tumours using FISH. Ploidy pattern
as determined by FISH did not significantly correlate with
pathological stage and GS, but aneuploidy was identified
more frequently (66%) in the tumours with total GS 8 or 9.
Seven (70%) of the tumours with lymph node metastases
showed aneuploidy.
Discussion
In this study, numerical aberrations were detected in 20
(71%) of 28 prostate cancers. This frequency is much higher
than that found by conventional metaphase cytogenetic
methods (karyotyping) (Micale et al., 1992; Arps et al.,
1993). These methods are used after tissue culture and may
result in a selective growth of cells with the highest mitotic
index and loss of chromosomal material (Polak et al., 1990).
In contrast, FISH using chromosome-specific probes enables
detection of numerical aberrations of chromosomes in
interphase, as well as metaphase, cells, and the technique
does not require tissue culture and can be applied to solid
tumours or paraffin-embedded tissues (Micale et al., 1993;
Persons et al., 1994). With interphase FISH, the selection that
takes place in the preparation of metaphase cells from
primary tumours can be avoided (Polak et al., 1990). FISH is
thus a useful technique for detecting numerical aberrations of
chromosomes.
In this study, we used the touch preparation method,
which does not require trypsin treatment and can be
performed in a short time. No significant difference was
found between results from preparations made with frozen-
stored BPH tissues and from fresh specimens, confirming that
frozen material is suitable for FISH. Similar results were
obtained for the prostate cancers (data not shown).
Prostate cancers are composed of heterogeneous popula-
tions of cells with divergent Gleason scores. When the extent
of cancer in the touched tissues did not exceed 80% of the
total area, we used samples made from frozen-store speci-
mens in which the presence of the cancer could be confirmed
by histological examination of cryostat sections. PIN and
adenomatous hyperplasia could be not seen in these touched
tissues. Recently, these precursors of prostate cancer were
demonstrated to have chromosomal abnormality (Alers et al.,
1995; Qian et al., 1995a, b). Because of the advantage of the
accurate sampling of cancer, FISH using frozen-stored
specimens is particularly suitable for detecting the numerical
aberrations of chromosomes of prostate cancers. We detected
numerical aberration of each chromosome in Japanese men
with prostate cancer using the criteria defined and described
in Materials and methods. The cell populations with
numerical aberration of any chromosome may represent a
minor tumour fraction or are the result of heterogeneity of
the tumour. One of the aims of this study is to correlate
numerical aberration of chromosomes with clinicopathologi-
cal data regardless of the cause of the aberration.
The gain of chromosome 8, the most frequent aberration
detected (57%, 16 of 28) among the five chromosomes, was
significantly associated with lymph node metastasisChromosome aberrations in prostate cancer
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(P<0.05). Trisomy and hypertetrasomy were found in three
quarters of the cancers. Trisomy 8 has been reported to be
one of the most common aberrations in haematological
malignancies (Kibbelaar et al., 1991; Amiel et al., 1995)
analysed by FISH. The biological significance of trisomy 8
for development and progression of prostate cancer is still
unclear. Genetic alterations, such as deletions or allelic loss,
involving in chromosome 8 have also been recently reported
(Bova et al., 1993; Macosca et al., 1994; Matsuyama et al.,
1994), suggesting the presence of putative tumour-suppressor
genes. A comparison of numerical aberrations and genetic
alterations of chromosome 8 would therefore be of interest.
Numerical aberration of chromosome 7 was the second
most frequent anomaly in the present study of cancers (50%,
14 of 28) and was the most significantly associated with a
higher GS (P<0.005) and with lymph node metastasis
(P<0.001). No equivalent aberration of chromosome 7 was
detected in benign prostatic specimens. Trisomy 7, which has
been described as a common anomaly in solid malignant
tumours (Weaver et al., 1988; Belge et al., 1994), was found
in four (14%) cases (Case 3, 16, 23, 27). In a previous study,
trisomy 7 was reported to serve as a novel marker for human
prostate cancer progression (Bandyk et al., 1994), and several
authors (Collard et al., 1987; Trent et al., 1990) have
suggested the presence of genes involved in metastasis and
invasion on chromosome 7. Enhanced expression of
epidermal growth factor receptor (EGFR) in pancreatic
cancers was also reported to be associated with either
structural or numerical alterations of chromosome 7 (Korc
et al., 1986). In addition, polysomy of chromosome 7 has
been linked with overexpression and amplification of the
EGF-receptor gene in human carcinoma cell lines (Helseth et
al., 1990). Our findings suggest that a gain of chromosome 7
in prostate cancer may play an important role in progression
and especially metastasis, and that this may be associated
with aggressive tumour behaviour and a poor prognosis in
patients with prostate cancer.
Aberrations in chromosome 17, X and Y, except two cases
with trisomy 17, accompanied numerical aberrations of
chromosome 7 or 8 and were detected in tumours with high
GS, lymph node metastasis or metastatic sites. These findings
suggest that multiple chromosomal alterations, including
those of chromosomes 7 or 8, are common in aggressive
prostate cancer. In contrast to the low incidence found here
(4%), loss of chromosome Y has been reported to be
frequent in prostate cancers in western countries. European
reports demonstrated that loss of Y was detected by FISH in
53% (Konig et al., 1994) and in 8 of 26 (31%) primary
prostatic adenocarcinomas (Breitkreuz et al., 1993). In
Americans, cytogenetic studies after short-term culture
showed that the most frequent numerical changes included
loss of chromosome Y in 4 of 32 (13%) adenocarcinomas of
the prostate from patients without prior treatment (Arps et
al., 1993), and that the most common clonal numerical
aberration was loss of Y in 5 of 62 (8%) prostatic
adenocarcinomas (Micale et al., 1992). A previous report
(Aly et al., 1994) combining conventional cytogenetic analysis
and FISH of short-term culture of benign prostatic
hyperplasia showed loss of chromosome Y to be the most
common chromosomal change. The cause of our low
frequency might be the result of technical variation.
Interphase cytogenetics is suitable for detecting gain of
chromosomes but it can be difficult to distinguish focal-
insufficient hybridisation from chromosomal loss (Wolman et
al., 1992). We diagnosed loss of chromosome X and Y only
when nuclei with perfectly hybridising signals and nuclei
without any signal were detected in the same sample in two
different trials, as recommended in a previous study (Henke
et al. 1994a). One report demonstrated that loss of
chromosome Y by FISH was noted in fewer cases (10%)
than would be expected from the literature (Henke et al.,
1994b). This policy might have resulted in the low frequency
of loss of sex chromosomes. An alternative explanation for
the discrepancy is the difference in material. Thus, genetic
changes in prostate cancer have been reported to differ
between Japanese and American men. The frequency of ras
mutations varies according to ethnic groups (Watanabe et al.,
1994a) and the p53 mutational spectrum in Japanese prostate
cancer patients is different from that in American prostate
cancer patients (Watanabe et al., 1994b). To clarify these
questions, we need to analyse the materials collected from
different ethnic groups with the same analytical procedures.
In conclusion, the present study showed that FISH
analysis of touch preparation slides from fresh or frozen-
stored specimens is a useful method for detecting numerical
aberration of individual chromosomes. In our series of
prostate cancers in Japanese men, numerical aberration of
chromosome 8 was the most common phenomenon, while
changes in chromosome 7 were suggested to have potential as
markers of aggressive tumour behaviour and a poor
prognosis. In addition, multiple numerical aberrations
involving several chromosomes, including chromosome 7
and/or 8, proved common in aggressive prostate cancers.
The association between genetic change and chromosomal
abnormality should be studied in detail. Our data on
chromosomal aberrations in Japanese prostate cancers
except those on the loss of chromosome Y are consistent
with those reported in Western countries.
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